The Roles of Adjuvant Supplements in Colorectal Cancer Patients on Chemotherapy – Reaping Benefits from Metabolic Crosstalk

References

• American Cancer Society: “Colorectal cancer,” http://www.cancer.org/acs/groups/cid/documents/webcontent/003096-pdf.pdf, 2015.
   Google Scholar
• Pericleous M, Mandair D, and Caplin ME: Diet and supplements and their impact on colorectal cancer. J Gastrointest Oncol 4, 409–423, 2013.
   PubMedGoogle Scholar
• Stewart BW, and Wild CP: World cancer report 2014, World Health Organization, https://www.iarc.fr/en/publications/pdfs-online/wcr/2003/WorldCancerReport.pdf, 2014.
   Google Scholar
• Sung JJ, Lau JY, Goh K, and Leung WK: Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol 6, 871–876, 2005.
   PubMed Web of Science ®Google Scholar
• Hassan MRA, Khazim WKW, Othman Z, Nik Mustapha NR, Mohd Said R, et al.: The second annual report of the national cancer patient registry-colorectal cancer 2008–2013. National Cancer Patient Registry-Colorectal Cancer and Clinical Research Centre (CRC), https://www.crc.gov.my/wp-content/uploads/documents/report/NCPR_CC_Registry_Report_2008-2013.pdf, 2014.
   Google Scholar
• Musa MB, Yusof FBM, Harun-Or-Rashid M, and Sakatmoto J: Cancers affecting women in Malaysia. Ann. Cancer Res. Therapy 19, 20–25, 2011.
   Google Scholar
• Scheer A, and Auer RAC: Surveillance after curative resection of colorectal cancer. Clin Colon Rectal Surg 22, 242–250, 2009.
   PubMedGoogle Scholar
• Lee JY, Chi SH, Jeon JY, Lee MK, Park JH, et al.: Effects of 12 weeks of probiotic supplementation on quality of life in colorectal cancer survivors: A double-blind, randomized, placebo-controlled trial. Dig Liver Dis 46, 1126–1132, 2014.
   PubMedGoogle Scholar
• Schiff E, and Ben-Arye E: Complementary therapies for side effects of chemotherapy and radiotherapy in the upper gastrointestinal system. Eur J Integr Med 3, 11–16, 2011.
   Web of Science ®Google Scholar
• Cheah KY, Howarth GS, and Bastian SEP: Grape seed extract dose-responsively decreases disease severity in a rat model of mucositis; concomitantly enhancing chemotherapeutic effectiveness in colon cancer cells. PLoS ONE 9, e85184, 2014.
   PubMed Web of Science ®Google Scholar
• Morland SL, Martins KJB, and Mazurak VC: n-3 polyunsaturated fatty acid supplementation during cancer chemotherapy. J Nutr Intermed Metab 5, 107–116, 2016.
   Google Scholar
• Brami C, Bao T, and Deng G: Natural products and complementary therapies for chemotherapy-induced peripheral neuropathy: a systematic review. Crit Rev Oncol Hematol 98, 325–334, 2016.
   PubMed Web of Science ®Google Scholar
• FAO Food and Nutrition Paper: Probiotics in food. Health and nutritional properties and guidelines for evaluation. World Health Organization Food and Agriculture Organization of the United Nations, Rome, 2006.
   Google Scholar
• Kahouli I, Tomaro-Duchesneau C, and Prakash S: Probiotics in colorectal cancer (CRC) with emphasis on mechanisms of action and current perspectives. J Med Microbiol 62, 1107–1123, 2013.
   PubMed Web of Science ®Google Scholar
• Wynendaele E, Verbeke F, D'Hondt M, Hendrix A, Van De Wiele C, et al.: Crosstalk between the microbiome and cancer cells by quorum sensing peptides. Peptides 64, 40–48, 2015.
   PubMed Web of Science ®Google Scholar
• Jacobi CA, Schulz C, and Malfertheiner P: Treating critically ill patients with probiotics: beneficial of dangerous. Gut Pathog 3, 1–5, 2011.
   PubMed Web of Science ®Google Scholar
• Kechagia M, Basoulia D, Konstantopoulous S, Dimitriadi D, Gyftopoulou, et al.: Health benefits of probiotics: a review. ISRN Nutr 2013, 1–7, 2013.
   Google Scholar
• Gill H, and Prasad J: Probiotics, immunomodulation, and health benefits. Bioactive Comp. Milk 606, 423–454, 2008.
   Google Scholar
• Allen SJ, Okoko B, Martinez E, Gregorio G, and Dans LF: Probiotics for treating infectious diarrhea. Cochrane Database Syst Rev 2, CD003048, 2004.
   PubMedGoogle Scholar
• Mattar AF, Drongowski RA, Coran AG, and Harmon CM: Effect of probiotics on enterocyte bacterial translocation in vitro. Pediatr Surg Int 17, 265–268, 2001.
   PubMed Web of Science ®Google Scholar
• Banasaz M, Norin E, Holma R, and Midtvedt T: Increased enterocyte production in gnotobiotic rats mono-associated with Lactobacillus rhamnosus GG. Appl Environ Microbiol 68, 3031–3034, 2002.
   PubMed Web of Science ®Google Scholar
• Khaled Z, Guandalini S, and Hendrickson B: Filtered supernatant of Lactobacillus GG (LGG) and VSL#3 prevent Crohn's disease (CD) mucosa adherent-E. coli-induced degradation of tight junctions (TJ) associated proteins occluding and Zo-1. J Pediatr Gastroenterol Nutr 36, p. 520, 2003.
   Google Scholar
• Mack DR, Ahrné S, Hyde L, Wei S, and Hollingsworth MA: Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro. Gut 52, 827–833, 2003.
   PubMed Web of Science ®Google Scholar
• Vaarala O: Immunological effects of probiotics with special reference to lactobacilli. Clin Exp Allergy 33, 1634–1640, 2003.
   PubMed Web of Science ®Google Scholar
• Salminen E, Eloma I, Minkkinen J, Vapaatalo H, and Salminen S: Preservation of intestinal integrity during radiotherapy using live Lactobacillus acidophilus cultures. Clin Radiol 39, 435–437, 1988.
   PubMed Web of Science ®Google Scholar
• Urbancsek H, Kazar T, Mezes I, and Neumann K: Results of a double-blind, randomized study to evaluate the efficacy and safety of Antibiophilus® in patients with radiation-induced diarrhea. Eur J Gastroenterol Hepatol 13, 391–396, 2001.
   PubMed Web of Science ®Google Scholar
• Delia P, Sansotta G, Donato V, Messina G, Frosina P, et al.: Prevention of radiation-induced diarrhea with the use of VSL#3, a new high-potency probiotic preparation. Am J Gastroenterol 97, 2150–2152, 2002.
   PubMed Web of Science ®Google Scholar
• Matsuda F, Chowdhury M, Saha A, Asahara T, Nomoto K, et al.: Evaluation of a probiotics, Bifidobacterium breve BBG-01, for enhancement of immunogenicity of an oral inactivated cholera vaccine and safety: a randomized, double-blind, placebo-controlled trial in Bangladeshi children under 5 years of age. Vaccine 29, 1855–1858, 2011.
   PubMed Web of Science ®Google Scholar
• Dong H, Rowland I, Tuohy K, Thomas LV, and Yaqoob P: Selective effects of Lactobacillus casei Shirota on T cell activations, natural killer cell activity and cytokine production. Clin Exp Immunol 161, 378–388, 2010.
   PubMed Web of Science ®Google Scholar
• Wong JM, de Souza R, Kendall CW, Emam A, and Jenkins DJ: Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol 40, 235–243, 2006.
   PubMed Web of Science ®Google Scholar
• Walker WA: Mechanisms of action of probiotics. Clin Infect Dis 46, 87–91, 2008.
   PubMed Web of Science ®Google Scholar
• Sarkar A, and Mandal S: Bifidobacteria-Insight into clinical outcomes and mechanisms of its probiotic action. Microbiol Res 192, 159–171, 2016.
   PubMed Web of Science ®Google Scholar
• Sun J, and Kato I: Gut microbiota, inflammation and colorectal cancer. Genes Dis 3, 130–143, 2016.
   PubMed Web of Science ®Google Scholar
• Rafter J, Bennett M, Caderni G, Clune Y, and Hughes R: Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients. Am J Clin Nutr 85, 488–496, 2007.
   PubMed Web of Science ®Google Scholar
• Gianotti L, Morelli L, Galbiati F, Rocchetti S, Coppola S, et al.: A randomized double-blind trial on periperative administration of probiotics in colorectal cancer patients. World J Gastroenterol 16, 167–175, 2010.
   PubMed Web of Science ®Google Scholar
• Wada M, Nagata S, Saito M, Shimizu T, Yamashiro Y, et al.: Effects of the enteral administration of Bifidobacterium breve on patients undergoing chemotherapy for pediatric malignancies. Support Care Cancer 18, 751–759, 2010.
   PubMed Web of Science ®Google Scholar
• Liu Z, Qin H, Yang Z, Xia Y, Liu W, et al.: Randomized clinical trial: the effects of perioperative probiotic treatment on barrier function and post-operative infectious complications in colorectal cancer surgery-a double-blind study. Aliment Pharmacol Ther 33, 50–63, 2011.
   PubMed Web of Science ®Google Scholar
• Osterlund P, Ruotsalainen T, Korpela R, Saxelin M, Ollus A, et al.: Lactobacillus supplementation for diarrhea related to chemotherapy of colorectal cancer: a randomized study. Br J Cancer 97, 1028–1034, 2007.
   PubMed Web of Science ®Google Scholar
• Mego M, Chovanec J, Vochyanova-Andrezalova I, Konkolovsky P, Mikulova M, et al.: Prevention of irinotecan-induced diarrhea by probiotics: A randomized double blind, placebo controlled pilot study. Complement Ther Med 23, 356–362, 2015.
   PubMed Web of Science ®Google Scholar
• Ohigashi S, Hoshino Y, Ohde S, and Onodera H: Functional outcome, quality of life, and efficacy of probiotics in postoperative patients with colorectal cancer. Surg Today 41, 1200–1206, 2011.
   PubMed Web of Science ®Google Scholar
• Biondo PD, Brindley DN, and Sawyer MB: The potential for treatment with dietary long-chain polyunsaturated n-3 fatty acids during chemotherapy. J Nutrl Biochem 19, 787–796, 2008.
   PubMed Web of Science ®Google Scholar
• Cockbain AJ, Toogood GJ, and Hull MA: Omega-3 polyunsaturated fatty acids for the treatment and prevention of colorectal cancer. Gut 61, 135–149, 2012.
   PubMed Web of Science ®Google Scholar
• de Deckere EA: Possible beneficial effect of fish and fish n-3 polyunsaturated fatty acids in breast and colorectal cancer. Eur J Cancer Prev 8, 213–221, 1999.
   PubMed Web of Science ®Google Scholar
• Mocellin MC, Camargo CQ, Nunes EA, Fiates GM, and Trindade EB: A systematic review and meta-analysis of the n-3 polyunsaturated fatty acids effects on inflammatory markers in colorectal cancer. Clin Nutr 35, 359–369, 2016.
   PubMed Web of Science ®Google Scholar
• Silva JAP, Fabre MES, and Waitzberg DL: Omega-3 supplements for patients in chemotherapy and radiotherapy: a systematic review. Clin Nutr 34, 359–366, 2015.
   PubMed Web of Science ®Google Scholar
• Benais-Pont G, Dupertuis YM, Kossovsky MP, Nouet P, Allal AS, et al.: ω-3 Polyunsaturated fatty acids and ionizing radiation: combined cytotoxicity on human colorectal adenocarcinoma cells. Nutrition 22, 931–939, 2006.
   PubMed Web of Science ®Google Scholar
• Yum HW, Na HY, and Surh YJ: Anti-inflammatory effects of docosahexaenoic acid: Implications for its cancer chemopreventive potential. Sem Cancer Biol 40–41, 141–159, 2016.
   PubMed Web of Science ®Google Scholar
• Eynard AR, and Navarro A: Crosstalk among dietary polyunsaturated fatty acids, urolithiasis, chronic inflammation, and urinary tract tumor risk. Nutrition 29, 930–938, 2013.
   PubMed Web of Science ®Google Scholar
• Eltweri AM, Thomas AL, Metcalfe M, Calder PC, Dennison AR, et al.: Potential applications of fish oils rich in omega-3 polyunsaturated fatty acids in the management of gastrointestinal cancer. Clin Nutr 36, 65–78, 2017.
   PubMed Web of Science ®Google Scholar
• Fradet V, Cheng I, Casey G, and White JS: Dietary omega-3 fatty acids, COX-2 genetic variation, and aggressive prostate cancer risk. Clin Cancer Res 15, 2559–2566, 2009.
   PubMed Web of Science ®Google Scholar
• Mocellin MC, Pastore e Silva Jde A, Camargo Cde Q, Fabre ME, Gevaerd S, et al.: Fish oil decreases C-reactive protein/albumin ratio improving nutritional prognosis and plasma fatty acid profile in colorectal cancer patients. Lipids 48, 879–888, 2013.
   PubMed Web of Science ®Google Scholar
• Read JA, Beale PJ, Volker DH, Smith N, Childs A, et al.: Nutrition intervention using an eicosapentaenoic acid (EPA)-containing supplement in patients with advanced colorectal cancer. Effects on nutritional and inflammatory status: a phase II trial. Support Care Cancer 15, 301–307, 2007.
   PubMed Web of Science ®Google Scholar
• Trabal B, Leyes P, Forga M, and Maurel J: Potential usefulness of an EPA-enriched nutritional supplement on chemotherapy tolerability in cancer patients without overt malnutrition. Nutr Hosp 25, 736–740, 2010.
   PubMed Web of Science ®Google Scholar
• Purasiri P, Murray A, Richardson S, Heys SD, Horrobin D, et al.: Modulation of cytokine production in vivo by dietary essential fatty acids in patients with colorectal cancer. Clin Sci (Lond) 87, 711–777, 1994.
   PubMed Web of Science ®Google Scholar
• Zhu MW, Tang DN, Hou J, Wei JM, Hua B, et al.: Impact of fish oil enriched total parenteral nutrition on elderly patients after colorectal cancer surgery. Chin Med J (Engl) 125, 178–181, 2012.
   PubMed Web of Science ®Google Scholar
• Khemissa F, Mineur L, Amsellem C, Assenat E, Ramdani M, et al.: A phase III study evaluating oral glutamine and transforming growth factor-beta on chemotherapy-induced toxicity in patients with digestive neoplasm. Dig Liver Dis 48, 327–332, 2016.
   PubMedGoogle Scholar
• Gaurav K, Goel RK, Shukla M, and Pandey M: Glutamine: a novel approach to chemotherapy-induced toxicity. Indian J Med Pediatr Oncol 3, 13–20, 2012.
   Google Scholar
• Sido B, Seel C, Hoclehnert A, Breitkreutz R, and Droge W: Low intestinal glutamine level and low glutaminase activity in Crohn's disease: a rational for glutamine supplementation? Dig Dis Sci 51, 2170–2179, 2006.
   PubMed Web of Science ®Google Scholar
• Savarese DM, Savy G, Vahdat I, Wischmeyer PE, and Corey B: Prevention of chemotherapy and radiation toxicity with glutamine. Cancer Trea Rev 29, 501–513, 2003.
   PubMed Web of Science ®Google Scholar
• Beutheu S, Ouelaa W, Guerin C, Belmonte L, Aziz M, et al.: Glutamine supplementation, but not combined glutamine and arginine supplementation, improves gut barrier function during chemotherapy-induced intestinal mucositis in rats. Clin Nutr 33, 694–701, 2014.
   PubMed Web of Science ®Google Scholar
• Choi K, Lee SS, Oh SJ, Lim SY, Lim SY, et al.: The effect of oral glutamine on 5-fluorouracil/leucovorin-induced mucositis/stomatitis assessed by intestinal permeability test. Clin Nutr 26, 57–62, 2007.
   PubMed Web of Science ®Google Scholar
• Decker-Baumann C, Buhl K, Frohmuller S, von Herbay A, Dueck M, et al.: Reduction of chemotherapy-induced side effects by parenteral glutamine supplementation in patients with metastatic colorectal cancer. Eur J Cancer 35, 202–207, 1999.
   PubMed Web of Science ®Google Scholar
• Scalise M, Pochini L, Galluccio M, and Indiveri C: Glutamine transport. From energy supply to sensing and beyond. Biochim Biophys Acta 1857, 1147–1157, 2016.
   PubMed Web of Science ®Google Scholar
• Rao R, and Samak G: Role of glutamine in protection of intestinal epithelial tight junctions. J Epithel Biol Pharmacol 5, 47–54, 2012.
   PubMedGoogle Scholar
• Daye D, and Wellen KE: Metabolic reprogramming in cancer: unravelling the role of glutamine in tumorigenesis. Semin Cell Dev Biol 23, 362–369, 2012.
   PubMed Web of Science ®Google Scholar
• Cluntun AA, Lukey MJ, Cerione RA, and Locasale JW: Glutamine metabolism in cancer: understanding the heterogeneity. Trends Cancer 3, 169–180, 2017.
   PubMed Web of Science ®Google Scholar
• Hensley CT, Wasti AT, and DeBerardinis RJ: Glutamine and cancer: cell biology, physiology, and clinical opportunities. J Clin Invest 123, 3678–3684, 2013.
   PubMed Web of Science ®Google Scholar
• Wang WS, Lin JK, Lin TC, Chen WS, Jiang JK, et al.: Oral glutamine is effective for preventing oxaliplatin-induced neuropathy in colorectal cancer patients. Oncologist 12, 312–319, 2007.
   PubMed Web of Science ®Google Scholar
• Berquin IM, Edwards IJ, and Chen YQ: Multi-targeted therapy of cancer by omega-3 fatty acids. Cancer Lett 269, 363–377, 2008.
   PubMed Web of Science ®Google Scholar